Low BCL-2 expression in acute leukemia with t(8;21) chromosomal abnormality

被引:18
作者
Shikami, M
Miwa, H
Nishii, K
Takahashi, T
Sekine, T
Mahmud, N
Nishikawa, M
Shiku, H
Kamada, N
Kita, K
机构
[1] Mie Univ, Sch Med, Dept Internal Med 2, Tsu, Mie 5148507, Japan
[2] Hiroshima Univ, Nucl Med & Biol Res Inst, Dept Hematol, Hiroshima, Japan
关键词
t(8; 21)AML; BCL-2; cell cycle;
D O I
10.1038/sj.leu.2401343
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In de novo 1(8;21) AML which shows terminal neutrophilic differentiation, the BCL-2 expression was found to he significantly lower than that in types of other AML regardless of the phenotypic differentiation status. An inverse correlation between BCL-2 expression and the S/G(2)/M population cells was observed in AML. The S/G(2)/M population in t(8;21)AML was larger than in the other types of AML. In t(8;21)AML, spontaneous apoptosis after a 12-h liquid culture was prominent, and the autonomous DNA synthesis after a 72-h liquid culture was low. G-CSF and IL-5 promoted the colony formation of t(8;21)AML cells. The data suggest that, in vivo, the tow BCL-2 in t(8;21)AML induced entry of cells from the G(0)/G(1) phase to S phase, but the cells easily die by apoptosis, in vitro. The low BCL-2 expression and the supportive effects of G-CSF and IL-5 in t(8;21)AML is thought to be a key phenomenon which might he related to the formation of the in vivo brood picture, such as prominent neutrophilic differentiation and eosinophilia. Cellular extracts from t(8;21)AML cell line Kasumi-1 bound to both the AML1 and CRE binding sites in the bcl-2 promoter, but none of the cellular extracts from de novo t(8;21)AML bound to either of these sites. The DNA binding activity of transactivators in de novo t(8;21)AML is different from that in Kasumi-1 cells probably due to the phosphorylation status.
引用
收藏
页码:358 / 368
页数:11
相关论文
共 50 条
[1]  
ASOU H, 1991, BLOOD, V77, P2031
[2]  
BRADBURY D, 1994, LEUKEMIA, V8, P786
[3]   COMPARATIVE QUANTITATIVE EXPRESSION OF BCL-2 BY NORMAL AND LEUKEMIC MYELOID CELLS [J].
BRADBURY, DA ;
RUSSELL, NH .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) :374-379
[4]   Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression [J].
Bradbury, DA ;
Aldington, S ;
Zhu, YM ;
Russell, NH .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (04) :671-675
[5]   Phorbol ester-stimulated phosphorylation of PU.1: Association with leukemic cell growth inhibition [J].
Carey, JO ;
Posekany, KJ ;
deVente, JE ;
Pettit, GR ;
Ways, DK .
BLOOD, 1996, 87 (10) :4316-4324
[6]   THE C-KIT LIGAND SUPPRESSES APOPTOSIS OF HUMAN NATURAL-KILLER-CELLS THROUGH THE UP-REGULATION OF BCL-2 [J].
CARSON, WE ;
HALDAR, S ;
BAIOCCHI, RA ;
CROCE, CM ;
CALIGIURI, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (16) :7553-7557
[7]   BCL-2 PROTOONCOGENE EXPRESSION IN NORMAL AND NEOPLASTIC HUMAN MYELOID CELLS [J].
DELIA, D ;
AIELLO, A ;
SOLIGO, D ;
FONTANELLA, E ;
MELANI, C ;
PEZZELLA, F ;
PIEROTTI, MA ;
DELLAPORTA, G .
BLOOD, 1992, 79 (05) :1291-1298
[8]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[9]  
EMA H, 1990, BLOOD, V75, P1941
[10]  
EMA H, 1990, BLOOD, V75, P350